Biogen Inc. announced a $2 billion investment to expand its manufacturing operations in North Carolina's Research Triangle Park (RTP), building on its 30-year history in the region. This investment, ...

(RTTNews) - Biogen Inc. (BIIB) said it intends to invest an additional $2 billion in its existing manufacturing footprint in North Carolina's Research Triangle Park. In the next few years, Biogen ...

Biogen will invest $2 billion more in its existing manufacturing plants in North Carolina, the drugmaker said on Monday, as it seeks to expand in the U.S. amid President Donald Trump's tariff threats.

Biogen Inc. intends to invest an additional $2 billion in its existing manufacturing footprint in North Carolina’s Research Triangle Park (RTP). Since breaking ground in 1995, Biogen’s manufacturing ...

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min One of North Carolina's largest ...

RESEARCH TRIANGLE PARK, N.C. (WTVD) -- Global biotechnology firm Biogen announced a major investment in its Research Triangle Park hub. The company said it will spend $2 billion to expand its North ...

Biogen could be manufacturing its “miracle pill” in less than two years at Research Triangle Park. Biogen could be manufacturing its “miracle pill” in less than two years at Research Triangle Park.

July 21 (Reuters) - Biogen (BIIB.O), opens new tab will invest $2 billion more in its existing manufacturing plants in North Carolina, the drugmaker said on Monday, as it seeks to expand in the U.S.

Biogen employs more than 1,500 workers and another 400 contractors at its Triangle campuses. 26,397 people played the daily Crossword recently. Can you solve it faster than others?26,397 people played ...